đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
This is a phase II, randomized, double-blind, active-controlled study to ev...
Status
Completed
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Start Date
2019-01-24
Trial ID
NCT03589768
This study will be conducted in two stages. In the diphtheria, tetanus, per...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06-16
Trial ID
NCT00228917
Treatments Being Tested
This pivotal safety trial aims to extend the safety database for BioNet rec...
Status
Active Not Recruiting
Location
Chula Clinical Research Center (Chula CRC)
Start Date
2025-02-08
Trial ID
NCT06798831
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
This is a study to evaluate the immune response and safety of GSK Biologica...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-11-11
Trial ID
NCT00197236
Treatments Being Tested
The aim of the study was to investigate the immunogenicity and safety of CY...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12-19
Trial ID
NCT02992418
The goal of this clinical trial is to investigate the safety and tetanus an...
Status
Completed
Location
ABO Plasma
Start Date
2023-05-05
Trial ID
NCT05662852
Treatments Being Tested
The present clinical study will assess the immunogenicity and reactogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00319852
Treatments Being Tested
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested